Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient

Little is known about the effect of oncolytic adenovirotherapy on pediatric tumors. Here we present the clinical case of a refractory neuroblastoma that responded positively to Celyvir (ICOVIR-5 oncolytic adenovirus delivered by autologous mesenchymal stem cells) for several months. We analyzed samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco-Luzón, Lidia, García-Mulero, Sandra, Sanz-Pamplona, Rebeca, Melen, Gustavo, Ruano, David, Lassaletta, Álvaro, Madero, Luís, González-Murillo, África, Ramírez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281487/
https://www.ncbi.nlm.nih.gov/pubmed/32354143
http://dx.doi.org/10.3390/cancers12051104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281487/
https://www.ncbi.nlm.nih.gov/pubmed/32354143
http://dx.doi.org/10.3390/cancers12051104

Ejemplares similares